DXRX
NEUTRALDiaceutics PLC Announces PDMR Shareholding and Share Incentive Plan
The diagnostic commercialization company provides an update on PDMR shareholding and its share incentive plan.
Diaceutics
139.00GBX
0.00%
Market Cap
117.63M
Volume
5.72k
5% of avg
P/E Ratio
2945.54
EPS (TTM)
0.05
Beta
0.95
Day Range
139.00p - 139.00p
52 Week Range
106.00p139.00p168.00p
139.00p
Upcoming Events
30 September 2026
Initial contract timeframe ends
High Impact Event
30 September 2028
Potential contract extension ends
High Impact Event
DXRX
NEUTRALDiaceutics Reports Strong H1 2025 Growth, Eyes Return to Profitability
The diagnostics commercialization firm reported 18% revenue growth and improved recurring revenue, but faces challenges with operating losses and decreased cash balance. It aims for full-year profitability amid market uncertainties.
DXRX
NEUTRALDiaceutics PLC Provides General Update
The diagnostic commercialization company provides a general update on its operations.
DXRX
NEUTRALDiaceutics PLC Announces Director Dealings
The healthcare company has announced changes to its major shareholdings.
DXRX
NEUTRALDiaceutics Announces PDMR Shareholding and Share Incentive Plan
The diagnostic commercialization company provides an update on PDMR shareholding and its share incentive plan.
DXRX
NEUTRALDiaceutics PLC Announces Major Shareholding Change
The healthcare information services company has reported a change in major shareholding, with Gresham House Asset Management Ltd now holding 16.29% of the voting rights.
DXRX
NEUTRALDiaceutics to Present at Canaccord Genuity Growth Conference
The healthcare technology company will present at an upcoming investor conference.
DXRX
NEUTRALDiaceutics Appoints New General Counsel and Company Secretary
The healthcare technology company has appointed a new Executive Vice President, Legal, General Counsel, and Group Company Secretary.
DXRX
NEUTRALDiaceutics PLC Announces Change in Shareholding
The healthcare services provider has announced a change in its major shareholding.
DXRX
NEUTRALDiaceutics PLC Issues Share Options to Management Team
The healthcare technology company has granted share options to its management team as part of its long-term incentive plan.